Curatis Holding AG | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Companies
Curatis Holding AG

PRESS RELEASE

published on 09/18/2025 at 07:00, 11 months 24 days ago

FDA minutes confirm positive outcome of meeting on 9. September 2025 – Corticorelin on track for Phase 3
Curatis Holding AG receives positive outcome confirmation from FDA meeting regarding corticorelin's Phase 3 development plan for patients with PTBE secondary to solid tumor brain metastases

Phase 3 Curatis Holding AG FDA Meeting Corticorelin PTBE
BRIEF

published on 09/15/2025 at 07:05, 11 months 27 days ago

Curatis annonce une croissance de son chiffre d'affaires et fait progresser le développement du C-PTBE-01

Partenariat Croissance Des Revenus Curatis Holding AG Réunion De La FDA Développement Du C-PTBE-01
BRIEF

published on 09/15/2025 at 07:05, 11 months 27 days ago

Curatis Reports Revenue Growth and Advances C-PTBE-01 Development

Revenue Growth Partnership Curatis Holding AG FDA Meeting C-PTBE-01 Development
PRESS RELEASE

published on 09/15/2025 at 07:00, 11 months 27 days ago

Curatis: Double-digit growth in core business and development milestone achieved for C-PTBE-01
Curatis Holding AG reports double-digit revenue growth in H1 2025, signing a significant partnership with Phoenix Labs for C-PTBE-01. Financials show a loss due to increased development expenses for corticorelin

Revenue Growth Partnership Financials Curatis Holding AG C-PTBE-01
BRIEF

published on 09/05/2025 at 07:05, 1 year ago

Curatis va augmenter ses revenus grâce à un partenariat avec Phoenix Labs

Suisse Accord De Distribution Croissance Des Revenus Curatis Laboratoires Phoenix
BRIEF

published on 09/05/2025 at 07:05, 1 year ago

Curatis to Boost Revenue with Phoenix Labs Partnership

Revenue Growth Distribution Agreement Switzerland Curatis Phoenix Labs
PRESS RELEASE

published on 09/05/2025 at 07:00, 1 year ago

Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues
Curatis Holding AG announces new distribution contract with Phoenix Labs (Ireland) for four products in Switzerland, expecting up to CHF 5 million additional annual revenues from October 2025

Revenue Growth Switzerland Curatis Holding AG Phoenix Labs Distribution Contract
BRIEF

published on 07/31/2025 at 06:05, 1 year 1 month ago

FDA Schedules Type B Meeting for Curatis' Phase 3 Corticorelin Trial

Phase 3 Trial Curatis Holding AG FDA Meeting Corticorelin PTBE Treatment
BRIEF

published on 07/31/2025 at 06:05, 1 year 1 month ago

La FDA organise une réunion de type B pour l'essai de phase 3 de Curatis sur la corticoréline

Essai De Phase 3 Curatis Holding AG Réunion De La FDA Corticoréline Traitement PTBE
PRESS RELEASE

published on 07/31/2025 at 06:00, 1 year 1 month ago

FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study
FDA confirms Type B meeting with Curatis Holding AG to review Phase 3 plan for investigational biologic corticorelin, targeting Peritumoral Brain Edema. Development aims to reduce steroid use in patients

FDA Phase 3 Study Curatis Holding AG Corticorelin Type B Meeting

Accesswire

Published on 09/12/2026 at 02:35, 11 hours 16 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 51 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 46 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 26 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 51 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 6 hours 20 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 36 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 40 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 6 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 35 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 6 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE